Date: Wednesday, March 23, 2022
Time: 1:00 PM - 2:00 PM ET
Your Host: BSI US and Poseidon
About this event
In the new virus age, the need for rigorous compliance with regulations and strict adherence to best-practice surrounding the quality, safe, and efficient distribution of medicines and vaccines worldwide has never been greater.
We are bringing together a collaborative partnership with Poseidon, the independent pharmaceutical logistics collaboration network, with the objective of bringing greater quality, and certainty to the global distribution of pharmaceuticals. With our joint resources and expertise, our goal is to develop and execute a multi-mode compliance and standards (MMCS) program to help promote, standardize, monitor and assess adherence to the GDP (good distribution practice) regulations that underpin global pharmaceutical logistics.
The MMCS program is relevant to pharmaceutical shippers, their end-to-end distribution partners and the wider community. The program will interpret the prevailing local and international GDP regulations and guidelines for each of the main long-haul transport modes and provide a full range of GDP support components, from collaborative standard development, to a shared assessment model, to training services.
The MMCS GDP initiative, the first of its type, promises to play a pivotal role in the pharmaceutical industry's drive for greater collaboration around supply chain standardization, resilience and regulatory conformance.
Join the workshop to:
- Gain an understanding of the MMCS program - need, objectives, scope
- Learn about the MMCS roadmap including actions, priorities and responsibilities
- Find out how collaboration and standardization present a new path through the regulatory minefield
- Learn about the structure and governance of the MMCS program
- Get involved with the creation of an MMCS Market Liaison Committee (MLC)
- Network with peers and have the opportunity to Q&A with the experts
All workshop participants have the opportunity to join the MMCS Consultation Cluster. The purpose of the group is to identify and consolidate the needs, views and experience of the industry's GDP stakeholders and sub-sectors across all roles, organizational types and geographic locations.
Courtney Soulsby - Sector Development Director – Healthcare and Life Sciences, BSI
Courtney has 10+ years’ experience working with the pharmaceutical industry and their downstream logistics supply chain gaining a deep understanding of regulation, compliance, quality, and other risk exposures when transporting medicines. Courtney works with key clients and industry to develop holistic solutions, strategies and programs, and also works to understand market challenges and future needs of the healthcare sector.
Alan Kennedy - Executive Director, Poseidon
Alan is a supply chain dynamics specialist who is focused on bringing the best-collaboration practice to pharma-logistics. Alan is Executive Director of Poseidon, the independent pharmaceutical logistics network, which has been conceived to radically transform the transportation of pharmaceutical products by sea, through the application of contemporary supply chain best-practice and structured, multi-party collaboration. He regularly presents and authors numerous papers.